Efficacy of rezafungin in a case of <i>Candida</i> spondylodiskitis
Rezafungin, which only requires weekly administration, is a potential candidate for difficult-to-treat infections that require long-term antimicrobial treatment, such as bone and joint infections. We report the first case of <i>Candida glabrata</i> spondylodiskitis successfully treated with 3 weeks of caspofungin followed by 10 weeks of rezafungin.
Authors
- Marin Lahouati (ORCID: https://orcid.org/0000-0003-0043-7336)
- Frédéric Gabriel (ORCID: https://orcid.org/0000-0002-9223-2516)
- Fabien Xuereb (ORCID: https://orcid.org/0000-0002-2240-196X)
- Maxime Lefranc (ORCID: https://orcid.org/0009-0003-1645-0030)
- Frédéric‐Antoine Dauchy (ORCID: https://orcid.org/0000-0002-7727-2851)
- Claire Tinévez
Institutions
- Université de Bordeaux (FR)
- Inserm (FR)
- Centre Hospitalier Universitaire de Bordeaux (FR)
- Biologie des maladies cardiovasculaires
Publication Details
- Journal
- Journal of Bone and Joint Infection
- Published
- 2024-10-07
- DOI
- https://doi.org/10.5194/jbji-9-213-2024
- Citations
- 5
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 1.95